XML 37 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Basis of Presentation (Tables)
6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Schedule of Adoption of New Accounting Standard
The adoption of the new benefit cost standard, new cash flows standard and new revenue standard resulted in the following adjustments to previously reported results, with no change to the Consolidated Statement of Comprehensive Loss for the three months ended June 30, 2017:


















Consolidated Balance Sheet as of December 31, 2017

 
As Reported
 
Adjustments for New Revenue Standard
 
Additional Reclassifications
 
As Adjusted
 
(In thousands)
Assets
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
Cash and cash equivalents
$
103,247

 
$

 
$

 
$
103,247

Receivables:
 
 
 
 
 
 
 
Trade
103,611

 

 
(14,300
)
 
89,311

Other
17,697

 

 

 
17,697

Total receivables
121,308

 

 
(14,300
)
 
107,008

Inventories
106,795

 

 

 
106,795

Unbilled revenues

 
49,574

 
14,300

 
63,874

Other current assets
11,517

 

 

 
11,517

Total current assets
342,867

 
49,574

 

 
392,441

Land, mineral rights, property, plant and equipment
1,665,740

 

 

 
1,665,740

Less accumulated depreciation, depletion and amortization
923,905

 

 

 
923,905

Net land, mineral rights, property, plant and equipment
741,835

 

 

 
741,835

Advanced coal royalties
21,404

 

 

 
21,404

Restricted investments, reclamation deposits and bond collateral
200,194

 

 

 
200,194

Unbilled revenues, less current portion

 
225,245

 

 
225,245

Investment in joint venture
27,763

 

 

 
27,763

Other assets
55,036

 

 

 
55,036

Total Assets
$
1,389,099

 
$
274,819

 
$

 
$
1,663,918

 
 
 
 
 
 
 
 
Liabilities and Shareholders’ Deficit
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
Current installments of long-term debt
$
983,427

 
$

 
$

 
$
983,427

Accounts payable and accrued expenses:
 
 
 
 
 
 
 
Trade and other accrued liabilities
121,489

 

 

 
121,489

Interest payable
22,840

 

 

 
22,840

Production taxes
41,688

 

 

 
41,688

Postretirement medical benefits
14,734

 

 

 
14,734

Deferred revenue
5,068

 
(1,867
)
 

 
3,201

Asset retirement obligations
48,429

 

 

 
48,429

Other current liabilities
9,401

 

 

 
9,401

Total current liabilities
1,247,076

 
(1,867
)
 

 
1,245,209

Long-term debt, less current installments
64,980

 

 

 
64,980

Postretirement medical benefits, less current portion
317,407

 

 

 
317,407

Pension and SERP obligations, less current portion
43,585

 

 

 
43,585

Deferred revenue, less current portion
1,984

 
(1,984
)
 

 

Asset retirement obligations, less current portion
426,038

 

 

 
426,038

Other liabilities
31,477

 

 

 
31,477

Total liabilities
2,132,547

 
(3,851
)
 

 
2,128,696

Shareholders’ deficit:
 
 
 
 
 
 
 
Common stock of $0.01 par value: Authorized 30,000,000 shares; Issued and outstanding 18,771,643 shares at December 31, 2017
188

 

 

 
188

Other paid-in capital
250,494

 

 

 
250,494

Accumulated other comprehensive loss
(160,525
)
 
1,826

 

 
(158,699
)
Accumulated deficit
(829,107
)
 
276,844

 

 
(552,263
)
Total shareholders’ deficit
(738,950
)
 
278,670

 

 
(460,280
)
Noncontrolling interests in consolidated subsidiaries
(4,498
)
 

 

 
(4,498
)
Total deficit
(743,448
)
 
278,670

 

 
(464,778
)
Total Liabilities and Shareholders' Deficit
$
1,389,099

 
$
274,819

 
$

 
$
1,663,918






Consolidated Statement of Operations for the three months ended June 30, 2017

 
As Reported
 
Adjustments for New Revenue Standard
 
Adjustments for New Net Periodic Benefit Cost Standard
 
As Adjusted
 
(In thousands, except per share data)
Revenues
$
323,025

 
$
4,289

 
$

 
$
327,314

Cost, expenses and other:
 
 
 
 
 
 
 
Cost of sales (exclusive of depreciation, depletion and amortization, shown separately)
271,909

 

 
408

 
272,317

Depreciation, depletion and amortization
39,497

 

 

 
39,497

Selling and administrative
30,166

 

 
(1,839
)
 
28,327

Heritage health benefit expenses
3,306

 

 
(2,305
)
 
1,001

Loss on sale/disposal of assets
133

 

 

 
133

Derivative loss
481

 

 

 
481

Income from equity affiliates
(1,400
)
 

 

 
(1,400
)
 
344,092

 

 
(3,736
)
 
340,356

Operating loss
(21,067
)
 
4,289

 
3,736

 
(13,042
)
Other (expense) income:
 
 
 
 
 
 
 
Interest expense
(30,109
)
 

 

 
(30,109
)
Interest income
1,038

 

 

 
1,038

Loss on foreign exchange
(1,185
)
 
48

 

 
(1,137
)
Other income (expense)
302

 

 
(3,736
)
 
(3,434
)
 
(29,954
)
 
48

 
(3,736
)
 
(33,642
)
Loss before income taxes
(51,021
)
 
4,337

 

 
(46,684
)
Income tax benefit
(501
)
 
99

 

 
(402
)
Net loss
(50,520
)
 
4,238

 

 
(46,282
)
Less net loss attributable to noncontrolling interest
(138
)
 

 

 
(138
)
Net loss applicable to common shareholders
$
(50,382
)
 
$
4,238

 
$

 
$
(46,144
)
 
 
 
 
 
 
 
 
Net loss per share applicable to common shareholders:
 
 
 
 
 
 
 
Basic and diluted
$
(2.69
)
 
$
0.22

 
$

 
$
(2.47
)
Weighted average number of common shares outstanding:
 
 
 
 
 
 
 
Basic and diluted
18,700

 

 

 
18,700
















Consolidated Statement of Operations for the six months ended June 30, 2017

 
As Reported
 
Adjustments for New Revenue Standard
 
Adjustments for New Net Periodic Benefit Cost Standard
 
As Adjusted
 
(In thousands, except per share data)
Revenues
$
662,762

 
$
11,564

 
$

 
$
674,326

Cost, expenses and other:
 
 
 
 
 
 
 
Cost of sales (exclusive of depreciation, depletion and amortization, shown separately)
556,513

 

 
824

 
557,337

Depreciation, depletion and amortization
76,064

 

 

 
76,064

Selling and administrative
60,592

 

 
(3,690
)
 
56,902

Heritage health benefit expenses
6,604

 

 
(4,609
)
 
1,995

Gain on sale/disposal of assets
(34
)
 

 

 
(34
)
Derivative gain
(1,904
)
 

 

 
(1,904
)
Income from equity affiliates
(2,919
)
 

 

 
(2,919
)
 
694,916

 

 
(7,475
)
 
687,441

Operating loss
(32,154
)
 
11,564

 
7,475

 
(13,115
)
Other (expense) income:
 
 
 
 
 
 
 
Interest expense
(59,371
)
 

 

 
(59,371
)
Interest income
1,931

 

 

 
1,931

Loss on foreign exchange
(1,652
)
 
50

 

 
(1,602
)
Other income (expense)
2,460

 

 
(7,475
)
 
(5,015
)
 
(56,632
)
 
50

 
(7,475
)
 
(64,057
)
Loss before income taxes
(88,786
)
 
11,614

 

 
(77,172
)
Income tax benefit
(965
)
 
191

 

 
(774
)
Net loss
(87,821
)
 
11,423

 

 
(76,398
)
Less net loss attributable to noncontrolling interest
(637
)
 

 

 
(637
)
Net loss applicable to common shareholders
$
(87,184
)
 
$
11,423

 
$

 
$
(75,761
)
 
 
 
 
 
 
 
 
Net loss per share applicable to common shareholders:
 
 
 
 
 
 
 
Basic and diluted
$
(4.68
)
 
$
0.61

 
$

 
$
(4.07
)
Weighted average number of common shares outstanding:
 
 
 
 
 
 
 
Basic and diluted
18,636

 

 

 
18,636
















Consolidated Statement of Comprehensive Loss for the six months ended June 30, 2017

 
As Reported
 
Adjustments for New Revenue Standard
 
As Adjusted
 
(In thousands)
Net loss
$
(87,821
)
 
$
11,423

 
$
(76,398
)
Other comprehensive income (loss)
 
 
 
 
 
Pension and other postretirement plans:
 
 
 
 
 
Amortization of accumulated actuarial gains and prior service costs, pension
1,177

 

 
1,177

Adjustments to accumulated actuarial gains and transition obligations, pension
301

 

 
301

Amortization of accumulated actuarial gains, transition obligations, and prior service costs, postretirement medical benefits
1,929

 

 
1,929

Tax effect of other comprehensive income
(1,819
)
 
(386
)
 
(2,205
)
Foreign currency translation adjustment gains
8,029

 

 
8,029

Unrealized and realized gains on available-for-sale debt securities
1,196

 

 
1,196

Other comprehensive income, net of income taxes
10,813

 
(386
)
 
10,427

Comprehensive loss
(77,008
)
 
11,037

 
(65,971
)
Less: Comprehensive loss attributable to noncontrolling interest
(637
)
 

 
(637
)
Comprehensive loss attributable to common shareholders
$
(76,371
)
 
$
11,037

 
$
(65,334
)

































Consolidated Statement of Cash Flows for the six months ended June 30, 2017

 
As Reported
 
Adjustments for New Revenue Standard
 
Adjustments for New Cash Flows Standard
 
As Adjusted
 
(In thousands)
Cash flows from operating activities:
 
 
 
 
 
 
 
Net loss
$
(87,821
)
 
$
11,423

 
$

 
$
(76,398
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
 
 
 
 
Depreciation, depletion and amortization
76,064

 

 

 
76,064

Accretion of asset retirement obligation
22,437

 

 

 
22,437

Share-based compensation
2,480

 

 

 
2,480

Non-cash interest expense
4,639

 

 

 
4,639

Amortization of deferred financing costs
5,193

 

 

 
5,193

Gain on derivative instruments
(1,904
)
 

 

 
(1,904
)
Loss on foreign exchange
1,652

 
(50
)
 

 
1,602

Income from equity affiliates
(2,919
)
 

 

 
(2,919
)
Distributions from equity affiliates
3,403

 

 

 
3,403

Deferred income tax benefit
(965
)
 
191

 

 
(774
)
Other
(1,752
)
 

 

 
(1,752
)
Changes in operating assets and liabilities:
 
 
 
 
 
 


Receivables
11,360

 

 

 
11,360

Inventories
7,706

 

 

 
7,706

Accounts payable and accrued expenses
(20,919
)
 

 

 
(20,919
)
Interest payable
532

 

 

 
532

Deferred revenue
(5,809
)
 
885

 

 
(4,924
)
Unbilled revenues

 
(12,449
)
 

 
(12,449
)
Other assets and liabilities
17,596

 

 

 
17,596

Asset retirement obligations
(20,819
)
 

 

 
(20,819
)
Net cash used in operating activities
10,154

 

 

 
10,154

Cash flows from investing activities:
 
 
 
 
 
 
 
Additions to property, plant and equipment
(13,104
)
 

 

 
(13,104
)
Proceeds from sales of restricted investments
21,605

 

 

 
21,605

Purchases of restricted investments
(23,614
)
 

 
(1,117
)
 
(24,731
)
Cash payments related to acquisitions and other
(3,580
)
 

 

 
(3,580
)
Proceeds from sales of assets
783

 

 

 
783

Receipts from loan and lease receivables
50,488

 

 

 
50,488

Other
(969
)
 

 

 
(969
)
Net cash provided by investing activities
31,609

 

 
(1,117
)
 
30,492

Cash flows from financing activities:
 
 
 
 
 
 
 
Repayments of long-term debt
(44,324
)
 

 

 
(44,324
)
Borrowings on revolving lines of credit
113,200

 

 

 
113,200

Repayments on revolving lines of credit
(113,200
)
 

 

 
(113,200
)
Other
(364
)
 

 

 
(364
)
Net cash used in financing activities
(44,688
)
 

 

 
(44,688
)
Effect of exchange rate changes on cash
463

 

 

 
463

Net decrease in cash and cash equivalents, including restricted cash
(2,462
)
 

 
(1,117
)
 
(3,579
)
Cash and cash equivalents, including restricted cash, beginning of period
60,082

 

 
69,533

 
129,615

Cash and cash equivalents, including restricted cash, end of period
$
57,620

 
$

 
$
68,416

 
$
126,036

Supplemental disclosures of cash flow information:
 
 
 
 
 
 
 
Cash paid for interest
$
48,931

 
$

 
$

 
$
48,931

Non-cash transactions:
 
 
 
 
 
 
 
Accrued purchases of property and equipment
$
1,009

 
$

 
$

 
$
1,009

Capital leases and other financing sources
480

 

 

 
480